Amyotrophic lateral sclerosis treatment

2007 
The provision of new amyotrophic lateral sclerosis therapeutics. Amyotrophic lateral sclerosis therapeutic agents characterized by containing a compound which does not have a xanthine dehydrogenase inhibitory activity and a substrate for purine salvage pathway.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    2
    Citations
    NaN
    KQI
    []